Day Zero Diagnostics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 56

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $21.6M

Day Zero Diagnostics General Information

Description

Developer of a sequencing-based infectious disease diagnostic system designed for microbiology and molecular labs. The company's system offers an ultra-high enrichment (UHE) capability that is capable of isolating and enriching pathogen deoxyribonucleic acid (DNA) from complex clinical samples, methods for rapid whole genome sequencing (WGS), and computational pipelines that can perform clinical-grade organism identification and antibiotic susceptibility profiling, enabling microbiology and molecular labs to perform organism identity (ID) and antibiotic susceptibility testing directly from clinical samples.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 250 Arsenal Place
  • Suite 320
  • Watertown, MA 02472
  • United States
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Acquirer
Corporate Office
  • 250 Arsenal Place
  • Suite 320
  • Watertown, MA 02472
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Day Zero Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
20. Merger/Acquisition 13-Jun-2025 $21.6M Completed Generating Revenue
19. Later Stage VC (Series B) 30-Aug-2023 Completed Generating Revenue
18. Grant 08-Aug-2023 Completed Generating Revenue
17. Grant 20-Oct-2022 Completed Generating Revenue
16. Grant 01-Jun-2022 Completed Generating Revenue
15. Later Stage VC (Series A1) 09-Feb-2022 Completed Generating Revenue
14. Grant 01-May-2020 Completed Generating Revenue
13. Grant 11-Jul-2019 Completed Generating Revenue
12. Grant 11-Jul-2019 $224K $13.1M Completed Generating Revenue
11. Early Stage VC (Series A) 20-Dec-2018 $8.57M $13.1M Completed Generating Revenue
To view Day Zero Diagnostics’s complete valuation and funding history, request access »

Day Zero Diagnostics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-1
Series A
Seed 5,394,000 $0.000100 $0.03 $0.68 $0.68 1x $0.68 11.98%
To view Day Zero Diagnostics’s complete cap table history, request access »

Day Zero Diagnostics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a sequencing-based infectious disease diagnostic system designed for microbiology and molecular labs. The c
Diagnostic Equipment
Watertown, MA
56 As of 2025

Redwood City, CA
 

Sunnyvale, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Day Zero Diagnostics Competitors (7)

One of Day Zero Diagnostics’s 7 competitors is Karius, a Venture Capital-Backed company based in Redwood City, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Karius Venture Capital-Backed Redwood City, CA
Inflammatix Venture Capital-Backed Sunnyvale, CA
Synthecon Formerly Accelerator/Incubator backed Houston, TX
Prellis Biologics Venture Capital-Backed Berkeley, CA
Pattern (Discovery Tools) Venture Capital-Backed Austin, TX
You’re viewing 5 of 7 competitors. Get the full list »

Day Zero Diagnostics Patents

Day Zero Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025136913-A1 Split sample processing Inactive 18-Dec-2023
WO-2025117627-A1 Internal process control Inactive 01-Dec-2023
WO-2025111453-A1 Sps mitigation Inactive 22-Nov-2023
WO-2022164968-A1 Methods for enriching microorganisms from low abundance clinical samples for dna sequencing Inactive 29-Jan-2021
WO-2022115318-A1 Universal primers for rapid bacterial genome detection Inactive 24-Nov-2020 C12Q1/689
To view Day Zero Diagnostics’s complete patent history, request access »

Day Zero Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Day Zero Diagnostics Former Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Becton, Dickinson and Company Corporation Minority
CARB-X University
Golden Seeds Venture Capital Minority
Golden Seeds Ventures Venture Capital Minority
HTA (Little Rock) Accelerator/Incubator Minority
You’re viewing 5 of 18 investors. Get the full list »

Day Zero Diagnostics FAQs

  • When was Day Zero Diagnostics founded?

    Day Zero Diagnostics was founded in 2016.

  • Where is Day Zero Diagnostics headquartered?

    Day Zero Diagnostics is headquartered in Watertown, MA.

  • What is the size of Day Zero Diagnostics?

    Day Zero Diagnostics has 56 total employees.

  • What industry is Day Zero Diagnostics in?

    Day Zero Diagnostics’s primary industry is Diagnostic Equipment.

  • Is Day Zero Diagnostics a private or public company?

    Day Zero Diagnostics is a Private company.

  • What is the current valuation of Day Zero Diagnostics?

    The current valuation of Day Zero Diagnostics is .

  • What is Day Zero Diagnostics’s current revenue?

    The current revenue for Day Zero Diagnostics is .

  • How much funding has Day Zero Diagnostics raised over time?

    Day Zero Diagnostics has raised $50.1M.

  • Who are Day Zero Diagnostics’s investors?

    Becton, Dickinson and Company, CARB-X, Golden Seeds, Golden Seeds Ventures, and HTA (Little Rock) are 5 of 18 investors who have invested in Day Zero Diagnostics.

  • Who are Day Zero Diagnostics’s competitors?

    Karius, Inflammatix, Synthecon, Prellis Biologics, and Pattern (Discovery Tools) are some of the 7 competitors of Day Zero Diagnostics.

  • When was Day Zero Diagnostics acquired?

    Day Zero Diagnostics was acquired on 13-Jun-2025.

  • Who acquired Day Zero Diagnostics?

    Day Zero Diagnostics was acquired by BioMérieux.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process